Check out the companies making headlines before the bell.
JD.com (JD) — Shares of JD.com gained 1.4% in early morning trading after the Chinese e-commerce giant appointed a new president. The company’s founder and CEO Richard Liu is stepping back from day-to-day operations, while Xu Lei, previously CEO of JD Retail, will take the president role and fulfill those duties.
Boeing (BA) — Boeing shares dipped 0.5% in premarket trading after Ryanair, one of Boeing’s biggest customers, said it ended talks to purchase 737 MAX 10 jets. The deal would have been worth tens of billions of dollars. Ryanair cited disputes over prices.
Moderna (MRNA) — The biotechnology and pharmaceutical stock ticked 0.5% lower in early morning trading after White House chief medical advisor Dr. Anthony Fauci said the rollout of Moderna’s Covid-19 vaccine booster shots in the U.S. could be delayed. Fauci said Pfizer‘s booster shots will likely be ready by Sept. 20; Pfizer shares ticked 0.2% higher in the premarket.
Spotify (SPOT) — Spotify shares gained 3.9% in the premarket after KeyBanc upgraded the music streamer’s stock to overweight from equal weight. KeyBanc said Spotify is growing its user base faster than peers.
Johnson & Johnson (JNJ), Merck (MRK), Amgen (AMGN) — Morgan Stanley downgraded several large-cap pharmaceutical stocks, saying upside is limited for those names. The firm changed its ratings on Johnson & Johnson, Merck and Amgen to equal weight from overweight. All three names moved lower in the premarket.
Terminix (TMX) — Shares of Terminix added nearly 2% in the premarket after Bank of America double upgraded the stock to buy from underperform. Bank of America said the pest control company’s turnaround “will take time to fully deliver,” but it sees a “more positive risk-reward today.”
Cirrus Logic (CRUS) — Cirrus Logic shares gained more than 3% in early morning trading after Barclays upgraded the semiconductor stock to overweight from equal weight. Barclays sees further content gains at Apple benefiting Cirrus Logic over the next few years.
Become a smarter investor with CNBC Pro.
Get stock picks, analyst calls, exclusive interviews and access to CNBC TV.
Sign up to start a free trial today